More questions than answers for the use of inhaled nitric oxide in COVID-19
Review article
[키워드] acute respiratory distress
administration
anti-inflammatory actions
antiviral properties
approved
ARDS
bloodstream
clinical outcomes
Cohort studies
coronavirus disease
COVID-19
Factor
Hypoxemia
IMPROVE
improvements in oxygenation
inactivation
Inhaled
lung
mechanisms
Neonates
nitric oxide
off-label
Oxygenation
pathological conditions
patient selection
patients with COVID-19
Potential treatment
pulmonary hypertension
question
Randomized
Randomized controlled trial
Respiratory failure
retrospective
SARS-CoV-2
syndrome
systemic effect
therapy
translated
Treatment
variety
Vascular
Ventilated
[DOI] 10.1016/j.niox.2022.05.001 [Article Type] Review article
[DOI] 10.1016/j.niox.2022.05.001 [Article Type] Review article